Vaxcyte

Forecast & Rating11 analysts currently cover Vaxcyte, with about 90.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $109.00, about 87.5% upside from the current price of $58.13. Price targets range from $67.00 to $163.00 — a wide spread, showing clear disagreement over just how much Vaxcyte can rise. Historically, about 67.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Vaxcyte closely still see room for the stock to rise. Data as of Sep 4, 2026; for reference only and not investment advice.